Epirubicin Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00445 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary pulmonary lymphoma | KG + DL |
| 2 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 3 | small cell lung carcinoma | KG + DL |
| 4 | pulmonary blastoma | KG + DL |
| 5 | lung mixed small cell and squamous cell carcinoma | KG + DL |
| 6 | myeloid leukemia | KG + DL |
| 7 | upper aerodigestive tract neoplasm | KG + DL |
| 8 | salivary gland type cancer of the breast | KG + DL |
| 9 | breast papillomatosis | KG + DL |
| 10 | breast leiomyoma | KG + DL |
| 11 | breast lipoma | KG + DL |
| 12 | diabetic mastopathy | KG + DL |
| 13 | giant adenofibroma of the breast | KG + DL |
| 14 | benign neoplasm of male breast | KG + DL |
| 15 | intraductal breast papillomatosis | KG + DL |
| 16 | subareolar duct papillomatosis | KG + DL |
| 17 | infiltrating nipple syringomatous adenoma | KG + DL |
| 18 | fibroepithelial neoplasm | KG + DL |
| 19 | benign eccrine breast spiradenoma | KG + DL |
| 20 | granular cell tumor | KG + DL |
| 21 | breast cyst | KG + DL |
| 22 | adenosarcoma | KG + DL |
| 23 | non-proliferative fibrocystic change of the breast | KG + DL |
| 24 | breast myoepitheliosis | KG + DL |
| 25 | uterine ligament adenosarcoma | KG + DL |
| 26 | malignant mixed epithelial and mesenchymal tumor of cervix uteri | KG + DL |
| 27 | Ewing sarcoma | KG + DL |
| 28 | head and neck cancer | KG + DL |
| 29 | hereditary breast ovarian cancer syndrome | KG + DL |
| 30 | ganglioneuroblastoma (disease) | KG + DL |
| 31 | osteopathia striata with cranial sclerosis | KG + DL |
| 32 | retroperitoneal neoplasm | KG + DL |
| 33 | bladder exstrophy-epispadias-cloacal exstrophy complex | KG + DL |
| 34 | neuroblastoma | KG + DL |
| 35 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 36 | skull base chordoma | KG + DL |
| 37 | malignant neoplasm of acoustic nerve | KG + DL |
| 38 | paranasal sinus cancer | KG + DL |
| 39 | vestibule of mouth cancer | KG + DL |
| 40 | soft palate cancer | KG + DL |
| 41 | chronic myelogenous leukemia, BCR-ABL1 positive | KG + DL |
| 42 | bladder exstrophy (disease) | KG + DL |
| 43 | retromolar area cancer | KG + DL |
| 44 | Keipert syndrome | KG + DL |
| 45 | uveal cancer | KG + DL |
| 46 | middle ear cancer | KG + DL |
| 47 | inner ear cancer | KG + DL |
| 48 | external ear cancer | KG + DL |
| 49 | 2q33.1 microdeletion syndrome | KG + DL |
| 50 | axillary neoplasm | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.